Sanofi Buys Antibody Maker Kymab for $1.45B
The deal comes after Sanofi agreed to spend $3.4b for U.S. biotech company Principia Biopharma.
Use phrases "in quotes" or the tools below to better filter your results.
This is premium content
To read the full story, please upgrade your plan to Gold, Platinum, or Enterprise.
Upgrade plan